IMMUNOLOGIC BASIS ENIVR MODULATION OF AUTOIM ARTHRITIS
IMMUNOLOGIC BASIS ENIVR MODULATION OF AUTOIM ARTHRITIS
批准号:
6171234
负责人:
KAMAL D MOUDGIL
金额:
$14.85万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2002-08-31
中文摘要
描述(摘自调查人员摘要)
易感大鼠皮下注射可诱发佐剂性关节炎(AA)
注射热灭活结核分枝杆菌H37Ra,作为一种
人类类风湿性关节炎(RA)的极佳模型。关节炎大鼠和
RA患者对65千道尔顿(KDa)分枝杆菌产生T细胞反应
热休克蛋白(Bhsp65)。Bhsp65同时含有致关节炎和
保护性/调节性T细胞决定因素。热休克蛋白(HSPs)是
在原核生物和真核生物中都高度保守的蛋白质。这个
调查人员做了一项有趣的观察,发现
Fisher大鼠的AA非常直接地受到环境因素的调节
在屏障设施(BB-Fisher)饲养和饲养的F344大鼠易患
AA,而Fisher大鼠在传统的(CV)设施中饲养和维护
(CVFisher)对AA具有抗性。此外,BB-Fisher大鼠在转移时
进入一个CV设施并在那里呆了几周,获得了对AA的抵抗力。
然而,这种由BB-Fisher大鼠获得的AA抗性可以是
如果给大鼠喂食新霉素或酸化水(以防止或
减少环境因素对肠道的侵占)从#日开始
他们被转移到简历中心。令人惊讶的是,天真的简历-费舍尔,而不是BB-
Fisher大鼠自发提高T细胞对Bhsp65的反应,包括Bhsp65
C-末端决定因素(BCTD)[研究人员先前已表明
BCTD参与了Lewis大鼠急性AA的调节]。此外,
CV-Fisher大鼠的AA抗性可过继转移到幼稚的BB-
未分离的CV-Fisher大鼠脾细胞移植
在体外用BCTD重新刺激。这些初步发现提供了一种新的
微生物在自身免疫中的作用:保护自身免疫免受
自身免疫性疾病而不是疾病诱导(后者的影响已经
在其他几种自身免疫的动物模型中观察到)。调查人员
在这项探索性研究中,我将检验以下命题:
A)环境因素直接参与赋予对
AA至CV-Fisher大鼠。实验性重建BB-Fisher大鼠的实验研究
来自CV-Fisher大鼠的微生物菌群(为简单起见,这些
重组大鼠被称为BBCV-Fisher大鼠)应呈现这些
对AA耐药的大鼠。B)微生物菌群(包含Bhsp65的hsp6O同系物
结核分枝杆菌)诱导CV-和BBCV-Fisher大鼠抗AA
通过一种免疫机制。这一假设将通过启动来检验。
与结核分枝杆菌Bhsp65交叉反应的T细胞(分子
模仿)。这些T细胞的子集通过以下方式提供对再生障碍性贫血的保护
机制(S)将在本研究中定义。或者,微生物菌群可以
诱导潜在的致关节炎T细胞的免疫偏离。C)
CV-或BBCV-Fisher大鼠的“获得性”AA抵抗应采取过继措施
可通过定义的T细胞亚群(CD4/CD81)转移到幼年BB-Fisher大鼠。
这项研究的结果应该对以下两个方面具有重要意义
认识环境因素对类风湿关节炎发病的影响
在生活在不同地理条件下的人类人口中,
开发新的类风湿关节炎预防/治疗方法。
英文摘要
DESCRIPTION (Taken from the Investigator's Abstract)
Adjuvant arthritis (AA), inducible in susceptible rat strains by subcutaneous
injection of heat-killed Mycobacterium tuberculosis H37Ra, serves as an
excellent model for human rheumatoid arthritis (RA). Both arthritic rats and
RA patients develop T cell responses to the 65-kilodalton (kDa) mycobacterial
heat-shock protein (Bhsp65). Bhsp65 contains both arthritogenic and
protective/regulatory T cell determinants. Heat-shock proteins (hsps) are
highly conserved proteins both in prokaryotes and eukaryotes. The
investigators have made an interesting observation that the susceptibility to
AA of Fisher rats is very directly modulated by environmental agents: Fisher
F344 rats bred and raised in a barrier facility (BB-Fisher) are susceptible to
AA, whereas Fisher rats bred and maintained in a conventional (CV) facility
(CVFisher) are resistant to AA. Furthermore, BB-Fisher rats, when transferred
into a CV facility and kept there for several weeks, acquire resistance to AA.
However, this acquisition of AA-resistance by BB-Fisher rats can be
circumvented if rats are fed neomycin or acidified water (to prevent or
diminish colonization of gut by environmental agents) beginning on the day of
their transfer into the CV facility. Strikingly, naive CV-Fisher, and not BB-
Fisher rats, spontaneously raised T cell responses to Bhsp65, including Bhsp65
C-terminal determinants (BCTD) [the investigators have previously shown that
BCTD are involved in regulation of acute AA in the Lewis rat]. Furthermore,
AA-resistance of CV-Fisher rats can be adoptively transferred to naive BB-
Fisher rats by unfractionated splenic cells of naive CV-Fisher rats
restimulated in vitro with BCTD. These preliminary findings provide a novel
perspective on the role of microbes in autoimmunity: protection from an
autoimmune disease instead of disease induction (the latter effect has been
observed in several other animal models of autoimmunity). The investigators
will test the following propositions in this exploratory study:
A) Environmental agents are directly involved in conferring resistance against
AA to CV-Fisher rats. Experimental reconstitution of BB-Fisher rats with
microbial flora derived from CV-Fisher rats (for simplicity, these
reconstituted rats are referred to as BBCV-Fisher rats) should render these
rats resistant to AA. B) Microbial flora (containing hsp6O homologs of Bhsp65
of M. tuberculosis) induce protection from AA in CV- and BBCV-Fisher rats
through an immunological mechanism. This hypothesis will be tested by priming
T cells that are cross-reactive with Bhsp65 of M. tuberculosis (molecular
mimicry). A subset of these T cells serves to afford protection from AA by
mechanism(s) to be defined in this study. Alternatively, microbial flora may
induce immune deviation of potentially arthritogenic T cells. C) The
"acquired" AA-resistance of CV- or BBCV-Fisher rats should be adoptively
transferable to naive BB-Fisher rats by a defined T cell subset (CD4/CD81).
The results of this study should have important implications both for
understanding the influence of environmental factors on the pathogenesis of RA
in human populations living under different geographical conditions, and in
developing new preventive/therapeutic approaches for RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
-
批准号:10589192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
-
批准号:10612913
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2022
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
-
批准号:10452321
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2022
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Anti-arthritic activity and therapeutic use of novel joint-homing peptides
-
批准号:8998611
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Anti-arthritic activity and therapeutic use of novel joint-homing peptides
-
批准号:9339552
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis
-
批准号:8897016
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis
-
批准号:8638421
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Defining glomerulus-homing peptides for targeted drug delivery in lupus nephritis
-
批准号:8787075
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:8290064
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:8103241
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:7898955
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:7706203
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Cellular therapy of autoimmunity using antigen-expressing B cells
-
批准号:7532512
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Cellular therapy of autoimmunity using antigen-expressing B cells
-
批准号:7626023
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Modulation of Autoimmunity by Green Tea Polyphenols
-
批准号:7140044
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Modulation of Autoimmunity by Green Tea Polyphenols
-
批准号:6988778
-
项目类别:
-
资助金额:$17.78万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING
-
批准号:7020686
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING
-
批准号:6868054
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS
-
批准号:6953243
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:KAMAL D MOUDGIL
-
依托单位:
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS
-
批准号:6838430
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:KAMAL D MOUDGIL
-
依托单位:
海外基金